Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | EDNRA | P25101 | 2/20 | 0.45 |
| ▸ | EDNRB | P24530 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | CES1 | P23141 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7141149 | 1.00 | BACE1 (0.52) | BACE1TSHRSMN1; SMN2EDNRAEDNRB | |
| SCHEMBL8573735 | 1.00 | BACE1 (0.52) | BACE1TSHRSMN1; SMN2EDNRAEDNRB | |
| SCHEMBL3201279 | 1.00 | BACE1 (0.52) | BACE1TSHRSMN1; SMN2EDNRAEDNRB | |
| SCHEMBL8856846 | 1.00 | BACE1 (0.52) | BACE1TSHRSMN1; SMN2EDNRAEDNRB | |
| SCHEMBL8503544 | 1.00 | BACE1 (0.52) | BACE1TSHRSMN1; SMN2EDNRAEDNRB | |
| SCHEMBL15446338 | 0.88 | BACE1 (0.46) | BACE1TSHRMAPTALDH1A1LMNA | |
| SCHEMBL15446214 | 0.87 | TSHR (0.53) | BACE1TSHRSMN1; SMN2EDNRAEDNRB | |
| SCHEMBL7906596 | 0.86 | TSHR (0.54) | BACE1TSHRMAPTALDH1A1CA1 | |
| SCHEMBL7902731 | 0.86 | TSHR (0.54) | BACE1TSHRMAPTALDH1A1CA1 | |
| SCHEMBL7906590 | 0.86 | TSHR (0.54) | BACE1TSHRMAPTALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10975260-B2 | Monomers, polymers and coating formulations that comprise at least one N-halamine precursor, a cationic center and a coating incorporation group | UNIVERSITY OF MANITOBA (CA) | 2021-04-13 | — | — | US | claimed |
| US-9458270-B2 | Method for producing polydienes and polydiene copolymers with reduced cold flow | BRIDGESTONE CORPORATION (JP) | 2016-10-04 | — | — | US | claimed |
| EP-2780177-B1 | METHOD FOR PRODUCING POLYDIENES AND POLYDIENE COPOLYMERS WITH REDUCED COLD FLOW | BRIDGESTONE CORP (JP) | 2016-03-23 | — | — | EP | claimed |
| US-20140296445-A1 | Method For Producing Polydienes And Polydiene Copolymers With Reduced Cold Flow | BRIDGESTONE CORPORATION (JP) | 2014-10-02 | — | — | US | claimed |
| EP-2780177-A1 | METHOD FOR PRODUCING POLYDIENES AND POLYDIENE COPOLYMERS WITH REDUCED COLD FLOW | Bridgestone Corporation (JP) | 2014-09-24 | — | — | EP | claimed |
| CN-104023996-A | METHOD FOR PRODUCING POLYDIENES AND POLYDIENE COPOLYMERS WITH REDUCED COLD FLOW | BRIDGESTONE CORP | 2014-09-03 | — | — | CN | claimed |
| WO-2014030106-A2 | PROCESS FOR PREPARATION OF OPTICALLY ACTIVE (2R,3S)-3-(4- METHOXYPHENYL)GLYCIDIC ACID METHYL ESTER AND CIS LACTAM AND USES THEREOF | UNIMARK REMEDIES LTD. (IN) | 2014-02-27 | — | — | WO | claimed |
| WO-2013075074-A1 | METHOD FOR PRODUCING POLYDIENES AND POLYDIENE COPOLYMERS WITH REDUCED COLD FLOW | BRIDGESTONE CORPORATION (JP) | 2013-05-23 | — | — | WO | claimed |
| US-5756809-A | ADDITION OF ORTHO-AMINOTHIOPHENOL ONTO 3-(4'-METHOXYPHENYL)-GLYCIDIC ACID METHYL ESTER IN THE PRESENCE OF ALKALI METAL SALTS OF WEAK ACIDS AND IN THE PRESENCE OF CATALYTIC AMOUNTS OF IRON COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1998-05-26 | — | — | US | claimed |
| JP-2693248-B2 | — | — | 1997-12-24 | — | — | JP | claimed |
| EP-0779811-A1 | MYOCARDIAL PROTECTION USING BENZOTHIAZEPINONES | UNIVERSITE DE MONTREAL (CA) | 1997-06-25 | — | — | EP | claimed |
| EP-0773213-A2 | Method for the preparation of methyl (2RS,3RS)-3-(2'-aminophenylthio)-2-hydroxy-3-(4\"-methoxyphenyl)propionate | BAYER AG (DE) | 1997-05-14 | — | — | EP | claimed |
| WO-1996007415-A1 | MYOCARDIAL PROTECTION USING BENZOTHIAZEPINONES | UNIVERSITE DE MONTREAL (CA) | 1996-03-14 | — | — | WO | claimed |
| US-5274300-A | Patent withdrawn after O.G. published | SEPRACOR, INC. (US) | 1993-12-28 | — | — | US | claimed |
| EP-0440723-A4 | PROCESS FOR PREPARING OPTICALLY ACTIVE GLYCIDATE ESTERS | — | 1992-05-20 | — | — | EP | claimed |
| EP-0440723-A1 | PROCESS FOR PREPARING OPTICALLY ACTIVE GLYCIDATE ESTERS. | SEPRACOR INC (US) | 1991-08-14 | — | — | EP | claimed |
| WO-1990004643-A1 | PROCESS FOR PREPARING OPTICALLY ACTIVE GLYCIDATE ESTERS | SEPRACOR, INC. (US) | 1990-05-03 | — | — | WO | claimed |
| US-4908469-A | Contacting a 2-aminothiophenol with an optically active 3-(4-alkyloxyphenyl)glycidic acid acyclic alkyl ester | MARION LABORATORIES, INC. (US) | 1990-03-13 | — | — | US | claimed |
| EP-0342902-A2 | 2-Hydroxy-propanoic acid acyclic alkyl esters for benzothiazepines | MARION LABORATORIES, INC. (a Delaware corporation) (US) | 1989-11-23 | — | — | EP | claimed |
| JP-6335399-A | — | — | None | — | — | JP | disclosed |
| JP-10304875-A | — | — | None | — | — | JP | disclosed |
| US-12362387-B2 | Carbon fiber battery electrodes with ionic liquid and gel electrolytes | THE MITRE CORPORATION (US) | 2025-07-15 | — | — | US | disclosed |
| US-20240363897-A1 | CARBON FIBER BATTERY ELECTRODES WITH IONIC LIQUID AND GEL ELECTROLYTES | THE MITRE CORPORATION (US) | 2024-10-31 | — | — | US | disclosed |
| US-11978855-B2 | Carbon fiber battery electrodes with ionic liquid and gel electrolytes | THE MITRE CORPORATION (US) | 2024-05-07 | — | — | US | disclosed |
| US-11879038-B2 | Supramolecular gel supported on open-cell polymer foam | UNIVERSITE DE STRASBOURG (FR) | 2024-01-23 | — | — | US | disclosed |
| US-20220407107-A1 | CARBON FIBER BATTERY ELECTRODES WITH IONIC LIQUID AND GEL ELECTROLYTES | THE MITRE CORPORATION (US) | 2022-12-22 | — | — | US | disclosed |
| US-11456483-B2 | Carbon fiber battery electrodes with ionic liquid and gel electrolytes | THE MITRE CORPORATION (US) | 2022-09-27 | — | — | US | disclosed |
| EP-4028518-A1 | SUPRAMOLECULAR GEL SUPPORTED ON OPEN-CELL POLYMER FOAM | Université de Strasbourg (FR) | 2022-07-20 | — | — | EP | disclosed |
| WO-2021048199-A1 | SUPRAMOLECULAR GEL SUPPORTED ON OPEN-CELL POLYMER FOAM | UNIVERSITÉ DE STRASBOURG (FR) | 2021-03-18 | — | — | WO | disclosed |
| EP-3789427-A1 | SUPRAMOLECULAR GEL SUPPORTED ON OPEN-CELL POLYMER FOAM | Université de Strasbourg (FR) | 2021-03-10 | — | — | EP | disclosed |
| US-20200287240-A1 | Carbon Fiber Battery Electrodes With Ionic Liquid and Gel Electrolytes | THE MITRE CORPORATION (US) | 2020-09-10 | — | — | US | disclosed |
| US-10301397-B2 | Method for producing polydienes and polydiene copolymers with reduced cold flow | BRIDGESTONE CORPORATION (JP) | 2019-05-28 | — | — | US | disclosed |
| US-20160340447-A1 | METHOD FOR PRODUCING POLYDIENES AND POLYDIENE COPOLYMERS WITH REDUCED COLD FLOW | BRIDGESTONE CORPORATION (JP) | 2016-11-24 | — | — | US | disclosed |
| US-9458270-B2 | Method for producing polydienes and polydiene copolymers with reduced cold flow | BRIDGESTONE CORPORATION (JP) | 2016-10-04 | — | — | US | disclosed |
| EP-2780177-B1 | METHOD FOR PRODUCING POLYDIENES AND POLYDIENE COPOLYMERS WITH REDUCED COLD FLOW | BRIDGESTONE CORP (JP) | 2016-03-23 | — | — | EP | disclosed |
| US-20140296445-A1 | Method For Producing Polydienes And Polydiene Copolymers With Reduced Cold Flow | BRIDGESTONE CORPORATION (JP) | 2014-10-02 | — | — | US | disclosed |
| EP-2780177-A1 | METHOD FOR PRODUCING POLYDIENES AND POLYDIENE COPOLYMERS WITH REDUCED COLD FLOW | Bridgestone Corporation (JP) | 2014-09-24 | — | — | EP | disclosed |
| CN-104023996-A | METHOD FOR PRODUCING POLYDIENES AND POLYDIENE COPOLYMERS WITH REDUCED COLD FLOW | BRIDGESTONE CORP | 2014-09-03 | — | — | CN | disclosed |
| WO-2014030106-A2 | PROCESS FOR PREPARATION OF OPTICALLY ACTIVE (2R,3S)-3-(4- METHOXYPHENYL)GLYCIDIC ACID METHYL ESTER AND CIS LACTAM AND USES THEREOF | UNIMARK REMEDIES LTD. (IN) | 2014-02-27 | — | — | WO | disclosed |
| WO-2013075074-A1 | METHOD FOR PRODUCING POLYDIENES AND POLYDIENE COPOLYMERS WITH REDUCED COLD FLOW | BRIDGESTONE CORPORATION (JP) | 2013-05-23 | — | — | WO | disclosed |
| US-7671238-B2 | Arylamino-arylpropanolamine derivatives and methods of their use | WYETH LLC (US) | 2010-03-02 | — | — | US | disclosed |
| US-7629400-B2 | Image making medium | HYMAN SYDNEY | 2009-12-08 | — | — | US | disclosed |
| US-20090099164-A1 | Phenylaminopropanol Derivatives and Methods of Their Use | WYETH (US) | 2009-04-16 | — | — | US | disclosed |
| US-7517899-B2 | Phenylaminopropanol derivatives and methods of their use | WYETH (US) | 2009-04-14 | — | — | US | disclosed |
| US-20090093469-A1 | Phenylaminopropanol Derivatives and Methods of Their Use | WYETH (US) | 2009-04-09 | — | — | US | disclosed |
| WO-2008042362-A1 | ARYLAMINO-ARYLPROPANOLAMINE DERIVATIVES AND METHODS OF THEIR USE | WYETH (US) | 2008-04-10 | — | — | WO | disclosed |
| US-20080085938-A1 | Arylamino-Arylpropanolamine Derivatives and Methods of Their Use | WYETH (US) | 2008-04-10 | — | — | US | disclosed |
| EP-1732887-B1 | 1-(1H-INDOL-1-YL)-3-(4-METHYLPIPERAZIN-1-YL)-1-PHENYL PROPAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF THE NOREPINEPHRINE (NE) AND THE SEROTONINE (5-HT) ACTIVITY AND THE MONOAMINE REUPTAKE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS (VMS) | WYETH CORP (US) | 2008-01-09 | — | — | EP | disclosed |
| WO-2007073847-A1 | NOVEL POLYPEPTIDE HAVING ESTERASE ACTIVITY AND RECOMBINANT ESTERASE AND USE THEREOF | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) | 2007-07-05 | — | — | WO | disclosed |
| US-7220870-B2 | Hydrolytic kinetic resolution of cyclic substrates | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2007-05-22 | — | — | US | disclosed |
| US-7220870-B2 | Hydrolytic kinetic resolution of cyclic substrates | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2007-05-22 | — | — | US | disclosed |
| EP-1732887-A1 | 1-(1H-INDOL-1-YL)-3-(4-METHYLPIPERAZIN-1-YL)-1-PHENYL PROPAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF THE NOREPINEPHRINE (NE) AND THE SEROTONINE (5-HT) ACTIVITY AND THE MONOAMINE REUPTAKE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS (VMS) | Wyeth (US) | 2006-12-20 | — | — | EP | disclosed |
| EP-1676614-A1 | Continuous process for the enantioselective enrichment and separation of enantiomers using centrifugal separation | DSM IP Assets B.V. (NL) | 2006-07-05 | — | — | EP | disclosed |
| WO-2005097744-A1 | 1-(1H-INDOL-1-YL)-3-(4-METHYLPIPERAZIN-1-YL)-1-PHENYL PROPAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF THE NOREPINEPHRINE (NE) AND THE SEROTONINE (5-HT) ACTIVITY AND THE MONOAMINE REUPTAKE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS (VMS) | WYETH (US) | 2005-10-20 | — | — | WO | disclosed |
| US-20050222148-A1 | Phenylaminopropanol derivatives and methods of their use | WYETH (US) | 2005-10-06 | — | — | US | disclosed |
| EP-1115881-B1 | PROCESS FOR THE ENZYMATIC KINETIC RESOLUTION OF 3-PHENYLGLYCIDATES BY TRANSESTERIFICATION WITH AMINOALCOHOLS | ZAMBON SPA (IT) | 2005-03-30 | — | — | EP | disclosed |
| US-6528531-B1 | Coccidiosis in poultry; | MERCK & CO., INC. | 2003-03-04 | — | — | US | disclosed |
| US-20030035917-A1 | Image making medium | HYMAN SYDNEY (US) | 2003-02-20 | — | — | US | disclosed |
| US-6521445-B1 | Stereoselective ester hydrolysis of racemic trans-3-(4-methoxyphenyl) glycidic acid ester using a hydrolase enzyme; resolution; diltiazem production | SEPRACOR, INC. | 2003-02-18 | — | — | US | disclosed |
| US-6451587-B1 | ASYMMETRIC REDUCTION OF A KETONE TO AN ALCOHOL, WHICH COMPRISES: CONTACTING THE KETONE WITH A MICROORGANISM, OR AN ENZYME REDUCTION SYSTEM CAPABLE OF ACCOMPLISHING THE SUBJECT REDUCTION COMPRISING AN ENZYME DERIVED FROM SAID MICROORGANISM | PFIZER INC. | 2002-09-17 | — | — | US | disclosed |
| EP-1115881-A1 | PROCESS FOR THE ENZYMATIC KINETIC RESOLUTION OF 3-PHENYLGLYCIDATES BY TRANSESTERIFICATION WITH AMINOALCOHOLS | ZAMBON GROUP S.p.A. (IT) | 2001-07-18 | — | — | EP | disclosed |
| US-6197953-B1 | ESTER INTERCHANGE, CRYSTALLIZATION, ISOMERIZATION; PREPARING 1,5-BENZOTHIAZEPINE DERIVATIVES | TANABE SEIYAKU CO., LTD. (JP) | 2001-03-06 | — | — | US | disclosed |
| US-6187936-B1 | TRANSESTERIFICATION OF MIXTURE OF TRANS ENANTIOMERS CATALYSED BY ENZYMES IN ORGANIC SOLVENT WITH AMINOALCOHOLS TO GIVE MIXTURE OF TRANS ESTERS, NON TRANSESTERIFIED AND TRANSESTERIFIED, HAVING OPPOSITE CONFIGURATION, SEPARATING | ZAMBON GROUP S.P.A. (IT) | 2001-02-13 | — | — | US | disclosed |
| WO-2000017384-A1 | PROCESS FOR THE ENZYMATIC KINETIC RESOLUTION OF 3-PHENYLGLYCIDATES BY TRANSESTERIFICATION WITH AMINOALCOHOLS | ZAMBON GROUP S.P.A. (IT) | 2000-03-30 | — | — | WO | disclosed |
| EP-0988297-A2 | PROCESS FOR PREPARING OPTICALLY ACTIVE PHENYLOXIRANE COMPOUNDS | Tanabe Seiyaku Co., Ltd. (JP) | 2000-03-29 | — | — | EP | disclosed |
| US-5998637-A | CRYSTALLIZATION; SEPARATION | TANABE SEIYAKU CO., LTD. (JP) | 1999-12-07 | — | — | US | disclosed |
| WO-1998056762-A2 | PROCESS FOR PREPARING OPTICALLY ACTIVE PHENYLOXIRANE COMPOUNDS | TANABE SEIYAKU CO., LTD. (JP) | 1998-12-17 | — | — | WO | disclosed |
| US-5847122-A | Process for preparing 1,5-benzothiazepine derivative | TANABE SEIYAKU CO., LTD. (JP) | 1998-12-08 | — | — | US | disclosed |
| JP-H10304875-A | NEW LIPASE PROTEIN | SHIONOGI & CO LTD | 1998-11-17 | — | — | JP | disclosed |
| EP-0861834-A1 | Process for preparing optically active trans-3-substituted glycidic acid ester | TANABE SEIYAKU CO., LTD. (JP) | 1998-09-02 | — | — | EP | disclosed |
| US-5756809-A | ADDITION OF ORTHO-AMINOTHIOPHENOL ONTO 3-(4'-METHOXYPHENYL)-GLYCIDIC ACID METHYL ESTER IN THE PRESENCE OF ALKALI METAL SALTS OF WEAK ACIDS AND IN THE PRESENCE OF CATALYTIC AMOUNTS OF IRON COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1998-05-26 | — | — | US | disclosed |
| US-5756809-A | ADDITION OF ORTHO-AMINOTHIOPHENOL ONTO 3-(4'-METHOXYPHENYL)-GLYCIDIC ACID METHYL ESTER IN THE PRESENCE OF ALKALI METAL SALTS OF WEAK ACIDS AND IN THE PRESENCE OF CATALYTIC AMOUNTS OF IRON COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1998-05-26 | — | — | US | disclosed |
| EP-0657544-B1 | Process for preparing optically active glycidate esters | SEPRACOR INC (US) | 1997-12-29 | — | — | EP | disclosed |
| EP-0792876-A2 | Process for preparing 1,5-benzothiazepine derivative | TANABE SEIYAKU CO., LTD. (JP) | 1997-09-03 | — | — | EP | disclosed |
| EP-0609031-B1 | Process for preparing benzothiazepine derivatives | SHIONOGI & CO (JP) | 1997-08-13 | — | — | EP | disclosed |
| EP-0779811-A1 | MYOCARDIAL PROTECTION USING BENZOTHIAZEPINONES | UNIVERSITE DE MONTREAL (CA) | 1997-06-25 | — | — | EP | disclosed |
| EP-0773213-A2 | Method for the preparation of methyl (2RS,3RS)-3-(2'-aminophenylthio)-2-hydroxy-3-(4\"-methoxyphenyl)propionate | BAYER AG (DE) | 1997-05-14 | — | — | EP | disclosed |
| EP-0773213-A2 | Method for the preparation of methyl (2RS,3RS)-3-(2'-aminophenylthio)-2-hydroxy-3-(4\"-methoxyphenyl)propionate | BAYER AG (DE) | 1997-05-14 | — | — | EP | disclosed |
| US-5580867-A | Myocardial protection during ischemia and reperfusion | UNIVERSITE DE MONTREAL (CA) | 1996-12-03 | — | — | US | disclosed |
| EP-0446771-B1 | Esterase from Serratia and process for preparing the same | TANABE SEIYAKU CO (JP) | 1996-06-19 | — | — | EP | disclosed |
| WO-1996007415-A1 | MYOCARDIAL PROTECTION USING BENZOTHIAZEPINONES | UNIVERSITE DE MONTREAL (CA) | 1996-03-14 | — | — | WO | disclosed |
| EP-0417785-B1 | Process for preparing optically active 3-phenylglycidic acid esters | TANABE SEIYAKU CO (JP) | 1995-12-06 | — | — | EP | disclosed |
| EP-0470575-B1 | Improved process for producing esterase | TANABE SEIYAKU CO (JP) | 1995-11-15 | — | — | EP | disclosed |
| US-5466838-A | Catalytic reaction of olefin with oxygen in the presence of aldehyde | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-11-14 | — | — | US | disclosed |
| EP-0540009-B1 | Process for producing epoxides | SUMITOMO CHEMICAL CO (JP) | 1995-08-30 | — | — | EP | disclosed |
| EP-0440723-B1 | PROCESS FOR PREPARING OPTICALLY ACTIVE GLYCIDATE ESTERS | SEPRACOR INC (US) | 1995-08-16 | — | — | EP | disclosed |
| EP-0657544-A1 | Process for preparing optically active glycidate esters | SEPRACOR, INC. (US) | 1995-06-14 | — | — | EP | disclosed |
| EP-0395302-B1 | Process for preparing 1,5-benzothiazepine derivatives | TANABE SEIYAKU CO (JP) | 1995-01-04 | — | — | EP | disclosed |
| JP-H06335399-A | PRODUCTION OF OPTICALLY ACTIVE ESTER OF TRANS-3-PHENYLGLYCIDIC ACID AND PRODUCTION OF BENZO(THI)AZEPINE | DSM NV | 1994-12-06 | — | — | JP | disclosed |
| US-5367087-A | Process for producing epoxide | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-11-22 | — | — | US | disclosed |
| EP-0362556-B1 | Method for preparing optically active 3-phenylglycidic acid esters | TANABE SEIYAKU CO (JP) | 1994-11-02 | — | — | EP | disclosed |
| EP-0612737-A1 | Process for preparing 1,5-benzothiazepine derivatives | TANABE SEIYAKU CO., LTD. (JP) | 1994-08-31 | — | — | EP | disclosed |
| US-5274300-A | Patent withdrawn after O.G. published | SEPRACOR, INC. (US) | 1993-12-28 | — | — | US | disclosed |
| US-5273897-A | Production of an esterase in a culture medium containing an ester of sorbitan or polyoxyethylene sorbitan and a fatty acid along with an amino acid | TANABE SEIYAKU CO., LTD. (JP) | 1993-12-28 | — | — | US | disclosed |
| EP-0302379-B1 | NAPHTHOTHIAZEPINE DERIVATIVES AND A PROCESS FOR PREPARING THE SAME | TANABE SEIYAKU CO., LTD. (JP) | 1993-09-29 | — | — | EP | disclosed |
| US-5244803-A | Stereoselective hydrolysis by microorganism in culture | TANABE SEIYAKU CO., LTD. (JP) | 1993-09-14 | — | — | US | disclosed |
| EP-0540009-A1 | Process for producing epoxides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-05-05 | — | — | EP | disclosed |
| US-5208156-A | Hydrolytic enzymes for carboxylic esters | TANABE SEIYAKU CO., LTD. (JP) | 1993-05-04 | — | — | US | disclosed |
| US-5198557-A | PROCESS FOR THE RESOLUTION OF 3-(4-SUBSTITUTED-PHENYL)-GLYCIDIC ACID DERIVATIVES | ZAMBON GROUP S.P.A. (IT) | 1993-03-30 | — | — | US | disclosed |
| US-5169779-A | Enzyme catalyzing the transesterification of dextrorotatory enantiomer into insoluble form by adding acid, salt or ester derivative of butanol | SYNTHELABO (FR) | 1992-12-08 | — | — | US | disclosed |
| EP-0498706-A1 | Process for the preparation of (-)-(2R,3S)-2,3-epoxy-3-(4-methoxyphenyl)methylpropionate | SYNTHELABO (FR) | 1992-08-12 | — | — | EP | disclosed |
| EP-0153692-B1 | METHOD FOR ISOMERIZATION A GLYCIDATE DERIVATIVE | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1992-07-29 | — | — | EP | disclosed |
| US-5128469-A | Catalytic ring closure with organic sulfonic acid; amidation | TANABE SEIYAKU CO., LTD. (JP) | 1992-07-07 | — | — | US | disclosed |
| EP-0440723-A4 | PROCESS FOR PREPARING OPTICALLY ACTIVE GLYCIDATE ESTERS | — | 1992-05-20 | — | — | EP | disclosed |
| EP-0353032-B1 | 1,5-BENZOTHIAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF CARDIOVASCULAR DISORDERS | Sankyo Company Limited (JP) | 1992-02-26 | — | — | EP | disclosed |
| EP-0470575-A1 | Improved process for producing esterase | TANABE SEIYAKU CO., LTD. (JP) | 1992-02-12 | — | — | EP | disclosed |
| US-5055575-A | Process for preparing 1,5-benzothiazepine derivatives | TANABE SEIYAKU CO., LTD. (JP) | 1991-10-08 | — | — | US | disclosed |
| EP-0446771-A2 | Esterase from Serratia and process for preparing the same | TANABE SEIYAKU CO., LTD. (JP) | 1991-09-18 | — | — | EP | disclosed |
| EP-0440723-A1 | PROCESS FOR PREPARING OPTICALLY ACTIVE GLYCIDATE ESTERS. | SEPRACOR INC (US) | 1991-08-14 | — | — | EP | disclosed |
| US-5002942-A | Calcium channel blockers for cardiovascular disorders | SANKYO COMPANY, LIMITED (JP) | 1991-03-26 | — | — | US | disclosed |
| EP-0417785-A1 | Process for preparing optically active 3-phenylglycidic acid esters | TANABE SEIYAKU CO., LTD. (JP) | 1991-03-20 | — | — | EP | disclosed |
| EP-0342902-A3 | 2-HYDROXY-PROPANOIC ACID ACYCLIC ALKYL ESTERS FOR BENZOTHIAZEPINES | MARION LABORATORIES, INC. (a Delaware corporation) (US) | 1991-01-30 | — | — | EP | disclosed |
| US-4950663-A | N-DESMETHYL, DEACETYL DILTIAZEM | DUMONT LOUIS (CA) | 1990-08-21 | — | — | US | disclosed |
| EP-0206662-B1 | THIAZOLIDINE DERIVATIVES AND PROCESS FOR PREPARING THE SAME | Tanabe Seiyaku Co., Ltd. (JP) | 1990-05-09 | — | — | EP | disclosed |
| WO-1990004643-A1 | PROCESS FOR PREPARING OPTICALLY ACTIVE GLYCIDATE ESTERS | SEPRACOR, INC. (US) | 1990-05-03 | — | — | WO | disclosed |
| EP-0362556-A1 | Method for preparing optically active 3-phenylglycidic acid esters | TANABE SEIYAKU CO., LTD. (JP) | 1990-04-11 | — | — | EP | disclosed |
| US-4908469-A | Contacting a 2-aminothiophenol with an optically active 3-(4-alkyloxyphenyl)glycidic acid acyclic alkyl ester | MARION LABORATORIES, INC. (US) | 1990-03-13 | — | — | US | disclosed |
| US-4908469-A | Contacting a 2-aminothiophenol with an optically active 3-(4-alkyloxyphenyl)glycidic acid acyclic alkyl ester | MARION LABORATORIES, INC. (US) | 1990-03-13 | — | — | US | disclosed |
| EP-0353032-A1 | 1,5-benzothiazepine derivatives, their preparation and their use in the treatment of cardiovascular disorders | Sankyo Company Limited (JP) | 1990-01-31 | — | — | EP | disclosed |
| US-4885375-A | Resolution of 3-(4-methoxyphenyl)glycidic acid with in situ conversion to alkyl esters | MARION LABORATORIES, INC. (US) | 1989-12-05 | — | — | US | disclosed |
| EP-0342902-A2 | 2-Hydroxy-propanoic acid acyclic alkyl esters for benzothiazepines | MARION LABORATORIES, INC. (a Delaware corporation) (US) | 1989-11-23 | — | — | EP | disclosed |
| EP-0342902-A2 | 2-Hydroxy-propanoic acid acyclic alkyl esters for benzothiazepines | MARION LABORATORIES, INC. (a Delaware corporation) (US) | 1989-11-23 | — | — | EP | disclosed |
| EP-0342903-A1 | Improved resolution of 3-(4-methoxyphenyl)-glycidic acid with in situ conversion to alkyl esters | MARION LABORATORIES, INC. (a Delaware corporation) (US) | 1989-11-23 | — | — | EP | disclosed |
| EP-0338893-A2 | Process for the preparation of (+)-(2S,3S)-3-(2-aminophenyl) thio-2-hydroxy-3-(4-methoxyphenyl) propionic acid methylester | SYNTHELABO (FR) | 1989-10-25 | — | — | EP | disclosed |
| US-4810705-A | BENZODIAZEPINE DERIVATIVE ANTAGONISTS | SANOFI (FR) | 1989-03-07 | — | — | US | disclosed |
| EP-0182273-B1 | 1,5-BENZOTHIAZEPINE DERIVATIVES, A PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITIONS AS WELL AS THE USE THEREOF | Tanabe Seiyaku Co., Ltd. (JP) | 1989-03-01 | — | — | EP | disclosed |
| EP-0302379-A1 | Naphthothiazepine derivatives and a process for preparing the same | TANABE SEIYAKU CO., LTD. (JP) | 1989-02-08 | — | — | EP | disclosed |
| EP-0158339-B1 | 1,5-BENZOTHIAZEPHINE DERIVATIVES, PROCESSES FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS | Tanabe Seiyaku Co., Ltd. (JP) | 1989-01-18 | — | — | EP | disclosed |
| US-4777178-A | CARDIOTONIC AGENTS | TANABE SEIYAKU CO., LTD. (JP) | 1988-10-11 | — | — | US | disclosed |
| EP-0098892-B1 | PROCESS FOR PREPARING 1,5-BENZOTHIAZEPINE DERIVATIVES | Tanabe Seiyaku Co., Ltd. (JP) | 1987-10-28 | — | — | EP | disclosed |
| US-4689327-A | N-substituted-2-[2-[2-(4-phenylpiperazine-1-yl)ethoxy]phenyl]-thiazolidine-3-carboxamides useful as cardiotonic agent | TANABE SEIYAKU CO., LTD. (JP) | 1987-08-25 | — | — | US | disclosed |
| US-4665068-A | HYPOTENSIVES, VASODILATORS | TANABE SEIYAKU CO., LTD. (JP) | 1987-05-12 | — | — | US | disclosed |
| EP-0206662-A1 | Thiazolidine derivatives and process for preparing the same | Tanabe Seiyaku Co., Ltd. (JP) | 1986-12-30 | — | — | EP | disclosed |
| US-4621150-A | METAL PERHALATE OR SULFONATE OR COMPLEX; GLYCIDATE, 2-HYDROXY-3-BUTENOATE, EPOXIDE | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1986-11-04 | — | — | US | disclosed |
| EP-0182273-A1 | 1,5-Benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof | Tanabe Seiyaku Co., Ltd. (JP) | 1986-05-28 | — | — | EP | disclosed |
| US-4585768-A | ANTICOAGULANTS | TANABE SEIYAKU CO., LTD. (JP) | 1986-04-29 | — | — | US | disclosed |
| EP-0167355-A2 | Thiazolidine derivative and processes for preparing the same | Tanabe Seiyaku Co., Ltd. (JP) | 1986-01-08 | — | — | EP | disclosed |
| EP-0158339-A2 | 1,5-Benzothiazephine derivatives, processes for preparing the same and pharmaceutical compositions | Tanabe Seiyaku Co., Ltd. (JP) | 1985-10-16 | — | — | EP | disclosed |
| EP-0153692-A2 | Method for isomerization a glycidate derivative | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1985-09-04 | — | — | EP | disclosed |
| EP-0059335-B1 | NOVEL PROCESS FOR PREPARING THREO-2-HYDROXY-3-(4-METHOXYPHENYL)-3-(2-NITROPHENYLTHIO)-PROPIONIC ESTER | Tanabe Seiyaku Co., Ltd. (JP) | 1985-05-15 | — | — | EP | disclosed |
| EP-0098892-A1 | Process for preparing 1,5-benzothiazepine derivatives | Tanabe Seiyaku Co., Ltd. (JP) | 1984-01-25 | — | — | EP | disclosed |
| US-4420628-A | Process for preparing threo-2-hydroxy-3-(4-methoxyphenyl)-3-(2-nitrophenylthio)-propionic ester | TANABE SEIYAKU CO., LTD. (JP) | 1983-12-13 | — | — | US | disclosed |
| US-4416819-A | Process for preparing 1,5-benzothiazephine derivatives | TANABE SEIYAKU CO., LTD. (JP) | 1983-11-22 | — | — | US | disclosed |
| EP-0059335-A1 | Novel process for preparing threo-2-hydroxy-3-(4-methoxyphenyl)-3-(2-nitrophenylthio)-propionic ester | Tanabe Seiyaku Co., Ltd. (JP) | 1982-09-08 | — | — | EP | disclosed |
| EP-0059335-A1 | Novel process for preparing threo-2-hydroxy-3-(4-methoxyphenyl)-3-(2-nitrophenylthio)-propionic ester | Tanabe Seiyaku Co., Ltd. (JP) | 1982-09-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099164-A1 | Phenylaminopropanol Derivatives and Methods of Their Use | PAH, PNMT, COMT | BACE1 3618/4885TSHR 3880/4885SMN1; SMN2 184/4885 |
| US-20050222148-A1 | Phenylaminopropanol derivatives and methods of their use | PAH, PNMT, COMT | BACE1 3618/4885TSHR 3880/4885SMN1; SMN2 184/4885 |
| US-20080085938-A1 | Arylamino-Arylpropanolamine Derivatives and Methods of Their Use | PNMT, PAH, SLC18A2 | BACE1 3681/4885TSHR 2696/4885SMN1; SMN2 322/4885 |
| US-20090093469-A1 | Phenylaminopropanol Derivatives and Methods of Their Use | PAH, PNMT, COMT | BACE1 3618/4885TSHR 3880/4885SMN1; SMN2 184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.